Drug Profile
Tigemonam
Alternative Names: SQ 30213; SQ 30836Latest Information Update: 25 Aug 1994
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antibacterials; Monobactams
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections